{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:14:11Z","timestamp":1792005251212,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014869","name":"BTG","doi-asserted-by":"publisher","award":["52733 1 0"],"award-info":[{"award-number":["52733 1 0"]}],"id":[{"id":"10.13039\/100014869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jhepr.2021.100232","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:54:11Z","timestamp":1611057251000},"page":"100232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation"],"prefix":"10.1016","volume":"3","author":[{"given":"Anya","family":"Burton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tataru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyfed","family":"Huws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.S.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys","family":"Pockett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyfed W.","family":"Huws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tataru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizz","family":"Paley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guruprasad","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100232_bib1","series-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11","year":"2013"},{"key":"10.1016\/j.jhepr.2021.100232_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2021.100232_bib4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.ejca.2015.07.034","article-title":"Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999\u20132007: results of EUROCARE-5","volume":"51","author":"Lepage","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2021.100232_bib5","unstructured":"Estimates of the population for the UK, England and Wales, Scotland and Northern Ireland. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/datasets\/populationestimatesforukenglandandwalesscotlandandnorthernireland Accessed 26 January\u00a02021."},{"key":"10.1016\/j.jhepr.2021.100232_bib6","series-title":"Human Mortality Database","year":"2020"},{"key":"10.1016\/j.jhepr.2021.100232_bib7","series-title":"Revision of the European Standard Population 2013 edition","year":"2013"},{"key":"10.1016\/j.jhepr.2021.100232_bib8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1536867X1201200408","article-title":"A\u00a0command to calculate age-standardized rates with efficient interval estimation","volume":"12","author":"Consonni","year":"2012","journal-title":"Stata J"},{"key":"10.1016\/j.jhepr.2021.100232_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz076","article-title":"Data resource profile: national cancer registration dataset in England","volume":"49","author":"Henson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhepr.2021.100232_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1536867X1501500112","article-title":"Estimating and modeling relative survival","volume":"15","author":"Dickman","year":"2015","journal-title":"Stata J"},{"key":"10.1016\/j.jhepr.2021.100232_bib11","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ejca.2004.07.007","article-title":"An alternative approach to age adjustment of cancer survival rates","volume":"40","author":"Brenner","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhepr.2021.100232_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.canep.2015.02.005","article-title":"Validation of the completeness and accuracy of the Northern Ireland cancer registry","volume":"39","author":"Kearney","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jhepr.2021.100232_bib13","series-title":"Incidence-based Mortality","year":"2020"},{"key":"10.1016\/j.jhepr.2021.100232_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028571","article-title":"Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study","volume":"9","author":"Driver","year":"2019","journal-title":"BMJ Open"},{"issue":"Suppl 1","key":"10.1016\/j.jhepr.2021.100232_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100232_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2021.100232_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2021.100232_bib19","doi-asserted-by":"crossref","first-page":"45846","DOI":"10.1038\/srep45846","article-title":"International incidence and mortality trends of liver cancer: a global profile","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2021.100232_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","article-title":"Global trends and predictions in hepatocellular carcinoma mortality","volume":"67","author":"Bertuccio","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ajg.2013.405","article-title":"Diagnosis of liver cirrhosis in England, a cohort study, 1998\u20132009: a comparison with cancer","volume":"109","author":"Ratib","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100232_bib22","series-title":"Annual Report of the Chief Medical Officer, Volume One, 2011, On the State of the Public\u2019s Health","author":"Davies","year":"2012"},{"key":"10.1016\/j.jhepr.2021.100232_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","article-title":"The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015","volume":"118","author":"Brown","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2021.100232_bib24","series-title":"Health Survey for England 2018","year":"2019"},{"issue":"1 Suppl","key":"10.1016\/j.jhepr.2021.100232_bib25","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jvh.13022","article-title":"Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy","volume":"26","author":"Vaziri","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100232_bib27","series-title":"The 2nd Atlas of variation in risk factors and healthcare for liver disease in England","year":"2017"},{"key":"10.1016\/j.jhepr.2021.100232_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"Ioannou","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100232_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jhep.2019.04.014","article-title":"Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia","volume":"71","author":"Alavi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/j.gastro.2019.12.030","article-title":"Recent decline in hepatocellular carcinoma rates in the United States","volume":"158","author":"Shiels","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100232_bib32","series-title":"Adult drinking habits in Great Britain: 2017","year":"2018"},{"key":"10.1016\/j.jhepr.2021.100232_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1258\/RSMSMJ.51.2.8","article-title":"Hepatitis C virus infection in Scotland: epidemiological review and public health challenges","volume":"51","author":"Hutchinson","year":"2006","journal-title":"Scott Med J"},{"key":"10.1016\/j.jhepr.2021.100232_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib36","doi-asserted-by":"crossref","first-page":"c951","DOI":"10.1136\/bmj.c951","article-title":"Multidisciplinary team working in cancer: what is the evidence?","volume":"340","author":"Taylor","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2021.100232_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2718","article-title":"Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women","volume":"344","author":"Kesson","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2021.100232_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4251\/wjgo.v5.i3.60","article-title":"Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer?","volume":"5","author":"Kersten","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jhepr.2021.100232_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2014.03.037","article-title":"Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma","volume":"61","author":"Cucchetti","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100232_bib40","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:27Z","timestamp":1762899927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2589555921000082"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100232","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100232"}}